GSK, Human Genome in co-development project

07/8/2005 | American City Business Journals

GlaxoSmithKline plans to co-develop a rheumatoid arthritis drug being tested by Human Genome Sciences. GSK said it would exercise its co-development option under a 1996 agreement between the two firms, with both companies sharing the costs of late-stage clinical trials and marketing costs if the drug is commercialized.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT